A carregar...
Registries supporting new drug applications
PURPOSE: Knowledge of the benefits and risks of new drugs is incomplete at the time of marketing approval. Registries offer the possibility for additional, post‐approval, data collection. For all new drugs, which were approved in the European Union between 2007 and 2010, we reviewed the frequency, t...
Na minha lista:
| Publicado no: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725674/ https://ncbi.nlm.nih.gov/pubmed/28983992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4332 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|